XomeDx®Prenatal - Comprehensive
New York
Approved
Clinical Utility
- Establishing a molecular diagnosis in a fetus with abnormal ultrasound findings
Lab Method
- Next-Gen Sequencing
Important Information
With a turnaround time (TAT) of 3-4 weeks, the fetal specimen and specimens from both biological parents must be submitted at the same time, along with clinical information, in order to begin testing. This test requires approval by GeneDx before ordering; please e-mail [email protected] to discuss cases prior to submitting samples. The XomeDxPrenatal Comprehensive fetal report will also include medically relevant pathogenic or likely pathogenic variants in genes expected to be related to the reported fetal phenotype. Variants of uncertain significance may be reported if there is compelling evidence to suggest clinical significance. In addition, variants of uncertain significance in novel candidate genes may be reported.
Insurance billing not accepted
Test Code
J499
CPT Codes*
81415x1, 81416x2
ABN Required
No
Turnaround Time**
3-4 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
Targeted Variant Testing